Your browser doesn't support javascript.
loading
Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.
Burgard, P; Mönch, E; Zschocke, J; Wendel, U; Langenbeck, U.
Afiliação
  • Burgard P; Centre for Paediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
  • Mönch E; Charité Universitätsmedizin Berlin, CampusVirchow-Klinikum, CC13, Berlin, Germany.
  • Zschocke J; Division of Human Genetics, Innsbruck Medical University, Innsbruck, Austria.
  • Wendel U; Children's Hospital, University of Düsseldorf, Düsseldorf, Germany.
  • Langenbeck U; Institute of Human Genetics, Frankfurt University Hospital, Frankfurt/Main, Germany. ulrich.langenbeck@gmx.net.
JIMD Rep ; 29: 77-84, 2016.
Article em En | MEDLINE | ID: mdl-26683466
ABSTRACT

BACKGROUND:

As part of the German Collaborative Study on Phenylketonuria (PKU)/Hyperphenylalaninaemia (HPA) Study Protocol, a Blaskovics protein loading test (180 mg phenylalanine (phe) protein equivalent per kg body weight and day for 72 h) had been applied to 145 children at the age of 6 months. For investigating possible age-related changes of metabolic phenotype, 51 of them received a 2nd loading test at 5 years of age.

METHODS:

Besides the analysis of blood phe levels, acidic phe transamination metabolites were quantified in urine.

RESULTS:

Compared to the 6-month data, the mean blood phe level 72 h after start of loading (Phe72) was found to be decreased by 7% (P = 0.06), whereas the mean urinary excretion (per 1.73 m2 body surface and day) of 2-hydroxyphenylacetic acid was increased 1.9-fold (P < 0.01). Corresponding with these analytical data, the kinetic model constant k out of metabolic plus renal phe disposal was found increased 1.3-fold in mean (P < 0.01).In 3 of the 51 patients, Phe72 was very high at 6 months while in the medium range at 5 years, suggesting that catabolic states may mimic a more severe metabolic defect.The blood phe level response of mild PKU (type II) was assigned identically at both ages in 7/9 patients. Diverging results were (i) response type III (mild hyperphenylalaninaemia) at 6 months and type II at 5 years and (ii) type II at 6 months and type III at age 5.

CONCLUSION:

Renal elimination of OHPAA and phe tolerance increase significantly between the age of 6 months and 5 years, suggesting that, at least in childhood, formation and/or renal disposal of phe transamination metabolites may be major distal determinants of phe tolerance.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: JIMD Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: JIMD Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha